Krol ADG - Search Results

1

The impact of treatment accuracy on proton therapy patient selection for oropharyngeal cancer patients.

Arts T, Breedveld S, de Jong MA, Astreinidou E, Tans L, Keskin-Cambay F, Krol ADG, van de Water S, Bijman RG, Hoogeman MS. Arts T, et al. Among authors: krol adg. Radiother Oncol. 2017 Dec;125(3):520-525. doi: 10.1016/j.radonc.2017.09.028. Epub 2017 Oct 23. Radiother Oncol. 2017. PMID: 29074078 Free article.

2

Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.

Senan S, van Sörnsen de Koste J, Samson M, Tankink H, Jansen P, Nowak PJ, Krol AD, Schmitz P, Lagerwaard FJ. Senan S, et al. Radiother Oncol. 1999 Dec;53(3):247-55. doi: 10.1016/s0167-8140(99)00143-7. Radiother Oncol. 1999. PMID: 10660205

3

Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.

Krol AD, Berenschot HW, Doekharan D, Henzen-Logmans S, van der Holt B, van 't Veer MB. Krol AD, et al. Radiother Oncol. 2001 Mar;58(3):251-5. doi: 10.1016/s0167-8140(00)00272-3. Radiother Oncol. 2001. PMID: 11230885

4

Long-term risk of secondary skin cancers after radiation therapy for Hodgkin's lymphoma.

Daniëls LA, Krol AD, Schaapveld M, Putter H, Jansen PM, Marijt EW, van Leeuwen FE, Creutzberg CL. Daniëls LA, et al. Radiother Oncol. 2013 Oct;109(1):140-5. doi: 10.1016/j.radonc.2013.06.041. Epub 2013 Aug 7. Radiother Oncol. 2013. PMID: 23932152

5

Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptation.

Kroesen M, Miladinovic V, Hutschemaekers SAJ, Jacobs J, van der Vos C, Wolf AL, Hoogeman MS, van Vulpen M, Bloem JL, P D S Dijkstra S, Peul WC, Penninkhof JJ, Krol ADG. Kroesen M, et al. Among authors: krol adg. Radiother Oncol. 2022 Jan;166:58-64. doi: 10.1016/j.radonc.2021.11.020. Epub 2021 Nov 26. Radiother Oncol. 2022. PMID: 34843840 Free article.

6

Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry.

Krol AD, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Krol AD, et al. Ann Oncol. 2003 Jan;14(1):131-9. doi: 10.1093/annonc/mdg004. Ann Oncol. 2003. PMID: 12488305 Free article.

7

Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.

Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M. Noordijk EM, et al. J Clin Oncol. 2006 Jul 1;24(19):3128-35. doi: 10.1200/JCO.2005.05.2746. Epub 2006 Jun 5. J Clin Oncol. 2006. PMID: 16754934 Clinical Trial.

8

Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors.

Koning CCE, Blank LECM, Koedooder C, van Os RM, van de Kar M, Jansen E, Battermann JJ, Beijert M, Gernaat C, van Herpen KAM, Hoekstra C, Horenblas S, Jobsen JJ, Krol ADG, Lybeert MLM, van Onna IEW, Pelger RCM, Poortmans P, Pos FJ, van der Steen-Banasik E, Slot A, Visser A, Pieters BR. Koning CCE, et al. Among authors: krol adg. Ann Oncol. 2012 Nov;23(11):2948-2953. doi: 10.1093/annonc/mds126. Epub 2012 Jun 19. Ann Oncol. 2012. PMID: 22718135 Free article.

9

Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance†.

Daniëls LA, Krol AD, de Graaf MA, Scholte AJ, Van't Veer MB, Putter H, de Roos A, Schalij MJ, Creutzberg CL. Daniëls LA, et al. Ann Oncol. 2014 Jun;25(6):1198-203. doi: 10.1093/annonc/mdu130. Epub 2014 Mar 31. Ann Oncol. 2014. PMID: 24692582 Free article. Clinical Trial.

10

Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.

Krul IM, Opstal-van Winden AWJ, Aleman BMP, Janus CPM, van Eggermond AM, De Bruin ML, Hauptmann M, Krol ADG, Schaapveld M, Broeks A, Kooijman KR, Fase S, Lybeert ML, Zijlstra JM, van der Maazen RWM, Kesminiene A, Diallo I, de Vathaire F, Russell NS, van Leeuwen FE. Krul IM, et al. Among authors: krol adg. Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):843-853. doi: 10.1016/j.ijrobp.2017.07.016. Epub 2017 Jul 18. Int J Radiat Oncol Biol Phys. 2017. PMID: 28888722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page